ArticleTherapeutic advances in infectious disease
Determinants of visceral leishmaniasis among patients admitted to selected public hospitals in Guji and Borena Zones, southern Oromia, Ethiopia: An unmatched case-control study.
Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Visceral leishmaniasis (VL) remains a significant public health concern in East Africa, with an estimated 30,000 cases reported annually. Ethiopia is among the most affected countries in the region, with the southern part of the country bearing a substantial share of the disease burden. Despite the high endemicity of VL in these areas, evidence regarding the factors contributing to disease occurrence among at-risk populations remains limited. Objectives: This study aims to identify the determinants of visceral leishmaniasis among patients admitted to selected public hospitals in Guji and Borena Zones, Southern Oromia, Ethiopia, in 2022. Design: A facility-based unmatched case-control study was conducted from April 15 to June 15, 2022. Methods: The study was conducted among randomly selected 335 (67 cases and 268 controls) patients in Nagele Borena and Yabelo General Hospitals of Guji and Borena Zones from April 15 to June 15/2022. A pretested and structured face-to-face interviewer administered questionnaire and chart review were used to collect the data. Data was entered into Epi Data version 4.6.0 and exported to SPSS version 25.0 for analysis. Bi-variable and multi variable binary logistic regression model were used to identify the determinants of VL. Adjusted odds ratio with 95% Confidence level and p-value of <0.05 were used to declare statistically significant associations. Result: A total of 335 study participants comprising 67 cases and 268 controls were included, with an overall response rate of 100%. In this study, presence of a dog in the household (AOR=7.2; 95%CI:3.6-18.1), presence of acacia trees around the home (AOR = 8.3; 95% CI: 4.2-17.1), presence of domestic animals in the household (AOR = 6.8; 95% CI: 2.3-16.7), no formal education (AOR = 3.6; 95% CI: 1.1-12.2), and termite hill around the home (AOR = 3.2; 95% CI: 2.02-9.3) were significantly associated with VL. Conclusion and recommendation: Our study identified several determinants of VL, that no formal education, presence of dog in the household, termite hill around the home, presence of domestic animals in the household and acacia trees around the home. Therefore, strengthening community awareness and promoting environmental risk-reduction strategies, including minimizing exposure to domestic animals, termite hills, and acacia trees in close proximity to households, may help reduce the risk of visceral leishmaniasis in the study area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.